{"filing":{"accession_number":"0001104659-26-093174","cik":"0002072188","ticker":"BIOT","company_name":"INSTINCT BIO TECHNICAL CO HOLDINGS INC.","form":"6-K","filing_date":"2026-08-10","report_date":"2026-08-10","primary_document":"tm2622710d1_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2072188/000110465926093174/tm2622710d1_6k.htm"},"events":[{"id":26470,"run_id":24059,"accession_number":"0001104659-26-093174","anchor_item_number":"EX-99.1","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"summary":"This exhibit announces a strategic collaboration agreement between Instinct Bio and PT PARVA CANDELA to develop a cosmetics business in Indonesia. The disclosure describes a material operational and strategic partnership involving joint market development, manufacturing, distribution, and revenue-sharing arrangements (50% profit share plus ingredient supply, royalties, and licensing fees). While the collaboration does not constitute a traditional M\u0026A transaction or acquisition, it represents a significant strategic business initiative that would affect a reasonable investor's assessment of the company's growth strategy and market expansion plans, particularly as the company explicitly identifies it as \"the third component of the Company's organic growth strategy.\"","company_name":"INSTINCT BIO TECHNICAL CO HOLDINGS INC.","ticker":"BIOT","filing_date":"2026-08-10","form":"6-K","submitted_at":null,"items":[{"id":27605,"accession_number":"0001104659-26-093174","item_number":"EX-99.1","item_title":"tm2622710d1_ex99-1.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"This exhibit announces a strategic collaboration agreement between Instinct Bio and PT PARVA CANDELA to develop a cosmetics business in Indonesia. The disclosure describes a material operational and strategic partnership involving joint market development, manufacturing, distribution, and revenue-sharing arrangements (50% profit share plus ingredient supply, royalties, and licensing fees). While the collaboration does not constitute a traditional M\u0026A transaction or acquisition, it represents a significant strategic business initiative that would affect a reasonable investor's assessment of the company's growth strategy and market expansion plans, particularly as the company explicitly identifies it as \"the third component of the Company's organic growth strategy.\"","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-10T15:05:39.973661+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":27605,"accession_number":"0001104659-26-093174","item_number":"EX-99.1","item_title":"tm2622710d1_ex99-1.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"This exhibit announces a strategic collaboration agreement between Instinct Bio and PT PARVA CANDELA to develop a cosmetics business in Indonesia. The disclosure describes a material operational and strategic partnership involving joint market development, manufacturing, distribution, and revenue-sharing arrangements (50% profit share plus ingredient supply, royalties, and licensing fees). While the collaboration does not constitute a traditional M\u0026A transaction or acquisition, it represents a significant strategic business initiative that would affect a reasonable investor's assessment of the company's growth strategy and market expansion plans, particularly as the company explicitly identifies it as \"the third component of the Company's organic growth strategy.\"","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-10T15:05:39.973661+00:00","company_name":"INSTINCT BIO TECHNICAL CO HOLDINGS INC.","ticker":"BIOT","filing_date":"2026-08-10"}]}